- Home
- OBIO vs GORO Comparison
OBIO vs GORO Comparison
Compare OBIO & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OBIO | GORO |
|---|---|---|
| Founded | 2017 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.2M | 212.0M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | OBIO | GORO |
|---|---|---|
| Price | $4.51 | $1.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $14.25 | $1.63 |
| AVG Volume (30 Days) | 165.7K | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.13 | ★ 91.80 |
| EPS | N/A | ★ N/A |
| Revenue | $33,482,000.00 | ★ $99,759,000.00 |
| Revenue This Year | N/A | $25.99 |
| Revenue Next Year | $12.43 | $5.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1169.22 | 51.78 |
| 52 Week Low | $2.20 | $0.35 |
| 52 Week High | $5.42 | $1.87 |
Technical Indicators
Market Signals| Indicator | OBIO | GORO |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 63.36 |
| Support Level | $4.02 | $0.79 |
| Resistance Level | $4.88 | $1.75 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 59.49 | 82.76 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.